期刊论文详细信息
Journal of Stroke
Does Clot Burden Score on Baseline T2*-MRI Impact Clinical Outcome in Acute Ischemic Stroke Treated with Mechanical Thrombectomy?
Marc Soudant1  Gabriella Hossu2  Imad Derraz3  Anne Laure Derelle3  Serge Bracard3  Romain Bourcier4  Sébastien Soize5  Helene Raoult6  Marie Tisserand7  Frederic Clarencon8  Catherine Oppenheim9  Wagih Ben Hassen9  Laurence Legrand9  Olivier Naggara9 
[1] Department of Biostatistics, CHRU Nancy, INSERM, University of Lorraine, Nancy, France;Department of CIC1433 Innovative Technology, CHRU Nancy, INSERM, University of Lorraine, Nancy, France;Department of Neuroradiology, CHRU Nancy, INSERM, University of Lorraine, Nancy, France;Department of Neuroradiology, CHU Nantes, Nantes, France;Department of Neuroradiology, CHU Reims, Reims, France;Department of Neuroradiology, CHU Rennes, Rennes, France;Department of Neuroradiology, Foch Hospital, Suresnes, France;Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France;Paris Descartes University, INSERM UMR 894 and Department of Neuroradiology, Sainte-Anne Hospital Center, Paris, France;
关键词: ischemic stroke;    magnetic resonance imaging;    thrombosis;    endovascular recanalization;   
DOI  :  10.5853/jos.2018.01921
来源: DOAJ
【 摘 要 】

Background and Purpose A long clot, defined by a low (0-6) clot burden score (CBS) assessed by T2*-MR sequence, is associated with worse clinical outcome after intravenous thrombolysis (IVT) for acute ischemic stroke than is a small clot (CBS, 7-10). The added benefit of mechanical thrombectomy (MT) might be higher in patients with long clot. The aim of this pre-specified post hoc analysis of the THRombectomie des Artères CErebrales (THRACE) trial was to assess the association between T2*-CBS, successful recanalization and clinical outcome. Methods Of 414 patients randomized in the THRACE trial, 281 patients were included in this analysis. Associations between T2*-CBS and clinical outcome on the modified Rankin Scale (mRS) at 3 months were tested. Results High T2*-CBS, i.e., small clot, was associated with a shift toward better outcome on the mRS; proportional odds ratio (POR) per point CBS was 1.19 (95% confidence interval [CI], 1.05 to 1.34) in the whole population, 1.34 (95% CI, 1.13 to 1.59) in IVT group, and 1.04 (95% CI, 0.87 to 1.23) in IVTMT group. After adjustment for baseline prognostic variables, the effect of the full scale T2*-CBS was not statistically significant in the whole population and for the IVTMT group but remains significant for the IVT group (POR, 1.32; 95% CI, 1.11 to 1.58). Conclusions A small clot, as assessed using T2*-CBS, is associated with improved outcome and may be used as a prognostic marker. Despite the worst outcome with long clot, the relative benefit of MT over IVT seemed to increase with low T2*-CBS and longer clot.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:6次